Active

NOVUSPHARMA (UK) LTD Financials

Company number
12461049Copy
Copy
Registered office
64 High Street, Pinner HA5 5QA
Incorporated
13/02/2020

Company snapshot

Status
Active
Employees
80 (2024)
Latest financial data
2024
Accounts type
Full

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2024.

Net Assets

£422.66K2024
-24.99%vs 2023

2023: £563.48K

Total Assets

£9.57M2024
52.81%vs 2023

2023: £6.27M

Cash in Bank

£943.33K2024
97.29%vs 2023

2023: £478.15K

Total Liabilities

£8.94M2024
62.07%vs 2023

2023: £5.51M

Employees

802024
+18vs 2023

2023: 62

In 2024, NOVUSPHARMA (UK) LTD reported net assets of £422.66K. The same filing shows total assets of £9.57M, cash in bank of £943.33K and total liabilities of £8.94M. Reported headcount was 80 in 2024. Total Liabilities rose from £5.51M in 2023 to £8.94M in 2024 (62.07%). Okredo holds filed figures for 2021–2024; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£422.66K2024
-24.99%from £563.48K in 2023

Year-on-year change

Net Assets as filed for 2021–2024. Every figure in this chart is also in the financial history table.

3-year financial trend (2022–2024)

How the figures NOVUSPHARMA (UK) LTD filed moved across the three reported years 2022, 2023 and 2024 — measured end to end rather than year on year.

Net Assets

£498.76K2022£422.66K2024
-15.3%vs 2022

-7.9% a year compound (CAGR)

Cash in Bank

£572.71K2022£943.33K2024
+64.7%vs 2022

+28.3% a year compound (CAGR)

Total Assets

£4.88M2022£9.57M2024
+96.3%vs 2022

+40.1% a year compound (CAGR)

Total Liabilities

£4.26M2022£8.94M2024
+110%vs 2022

+44.8% a year compound (CAGR)

Employees

592022802024
+35.6%vs 2022+21

Biggest increase

Total Liabilities+110%

£4.26M in 2022 to £8.94M in 2024

Biggest decrease

Net Assets-15.3%

£498.76K in 2022 to £422.66K in 2024

NOVUSPHARMA (UK) LTD's filings pull in both directions between 2022 and 2024. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in net assets, pointing to a weakening balance sheet. See the full year-by-year figures.

Ratios from the filed figures

Calculated from NOVUSPHARMA (UK) LTD's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
4.41%2024
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Liabilities to total assets
93.36%2024
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Cash to liabilities
10.55%2024
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Cash to total assets
9.85%2024
Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for NOVUSPHARMA (UK) LTD by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator2021202220232024
Net Assets£408.01K498.76K563.48K422.66K
Total Assets£5.12M4.88M6.27M9.57M
Cash in Bank£234.05K572.71K478.15K943.33K
Total Liabilities£4.58M4.26M5.51M8.94M
Employees58596280

NOVUSPHARMA (UK) LTD financials: frequently asked questions

Answered from this company's own filed figures.

Yes. Okredo holds filed figures for NOVUSPHARMA (UK) LTD covering 2021–2024, across 5 reported indicators. The most recent reported year is 2024.

NOVUSPHARMA (UK) LTD reported net assets of £422.66K for 2024. That compares with £563.48K in 2023, a change of -24.99%.

NOVUSPHARMA (UK) LTD reported total assets of £9.57M for 2024. That compares with £6.27M in 2023, a change of 52.81%.

NOVUSPHARMA (UK) LTD reported cash in bank of £943.33K for 2024. That compares with £478.15K in 2023, a change of 97.29%.

NOVUSPHARMA (UK) LTD reported 80 employees in 2024, compared with 62 in 2023.

Between 2022 and 2024, NOVUSPHARMA (UK) LTD's net assets fell by 15.3%, cash in bank rose by 64.7%, total assets rose by 96.3% and total liabilities rose by 110%. Net assets contracted at 7.9% a year across the two years to 2024, from £498.76K to £422.66K. Reported headcount went from 59 in 2022 to 80 in 2024 (+21).

Okredo holds reported figures for the years 2021, 2022, 2023, 2024. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.